메뉴 건너뛰기




Volumn 22, Issue 10, 2015, Pages 929-938

Tanshinone IIA enhances the effects of TRAIL by downregulating survivin in human ovarian carcinoma cells

Author keywords

Apoptosis; Ovarian cancer; p38 mitogen activated protein kinase (p38 MAPK); Survivin; Tanshinone IIA (TIIA); Tumor necrosis factor related apoptosis inducing ligand (TRAIL)

Indexed keywords

CASPASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; SURVIVIN; TANSHINONE IIA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; ABIETANE DERIVATIVE; ANTINEOPLASTIC AGENT; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; TANSHINONE; TNFSF10 PROTEIN, HUMAN;

EID: 84938594451     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2015.06.012     Document Type: Article
Times cited : (23)

References (28)
  • 3
    • 84874821284 scopus 로고    scopus 로고
    • New strategies in the treatment of ovarian cancer: Current clinical perspectives and future potential
    • Banerjee S., Kaye S.B. New strategies in the treatment of ovarian cancer: current clinical perspectives and future potential Clin. Cancer Res. 19 2013 961 968
    • (2013) Clin. Cancer Res. , vol.19 , pp. 961-968
    • Banerjee, S.1    Kaye, S.B.2
  • 4
    • 84856741780 scopus 로고    scopus 로고
    • Burn-induced apoptosis of cardiomyocytes is survivin dependent and regulated by PI3K/Akt, p38 MAPK and ERK pathways
    • Cao W., Xie Y.H., Li X.Q., Zhang X.K., Chen Y.T., Kang R., Chen X., Miao S., Wang S.W. Burn-induced apoptosis of cardiomyocytes is survivin dependent and regulated by PI3K/Akt, p38 MAPK and ERK pathways Basic Res. Cardiol. 106 2011 1207 1220
    • (2011) Basic Res. Cardiol. , vol.106 , pp. 1207-1220
    • Cao, W.1    Xie, Y.H.2    Li, X.Q.3    Zhang, X.K.4    Chen, Y.T.5    Kang, R.6    Chen, X.7    Miao, S.8    Wang, S.W.9
  • 7
    • 0038457729 scopus 로고    scopus 로고
    • Survivin expression in ovarian carcinoma: Correlation with apoptotic markers and prognosis
    • Cohen C., Lohmann C.M., Cotsonis G., Lawson D., Santoianni R. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis Mod. Pathol. 16 2003 574 583
    • (2003) Mod. Pathol. , vol.16 , pp. 574-583
    • Cohen, C.1    Lohmann, C.M.2    Cotsonis, G.3    Lawson, D.4    Santoianni, R.5
  • 8
    • 84875230886 scopus 로고    scopus 로고
    • On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics
    • Dimberg L.Y., Anderson C.K., Camidge R., Behbakht K., Thorburn A., Ford H.L. On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics Oncogene 32 2013 1341 1350
    • (2013) Oncogene , vol.32 , pp. 1341-1350
    • Dimberg, L.Y.1    Anderson, C.K.2    Camidge, R.3    Behbakht, K.4    Thorburn, A.5    Ford, H.L.6
  • 10
    • 84893861378 scopus 로고    scopus 로고
    • Targeting survivin in cancer: Novel drug development approaches
    • Groner B., Weiss A. Targeting survivin in cancer: novel drug development approaches BioDrugs 28 2014 27 39
    • (2014) BioDrugs , vol.28 , pp. 27-39
    • Groner, B.1    Weiss, A.2
  • 13
    • 34250774915 scopus 로고    scopus 로고
    • Activation of p38 mitogen-activated protein kinase by celecoxib oppositely regulates survivin and gamma-H2AX in human colorectal cancer cells
    • Hsiao P.W., Chang C.C., Liu H.F., Tsai C.M., Chiu T.H., Chao J.I. Activation of p38 mitogen-activated protein kinase by celecoxib oppositely regulates survivin and gamma-H2AX in human colorectal cancer cells Toxicol. Appl. Pharmacol. 222 2007 97 104
    • (2007) Toxicol. Appl. Pharmacol. , vol.222 , pp. 97-104
    • Hsiao, P.W.1    Chang, C.C.2    Liu, H.F.3    Tsai, C.M.4    Chiu, T.H.5    Chao, J.I.6
  • 14
    • 79953655787 scopus 로고    scopus 로고
    • Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin
    • Kelly R.J., Lopez-Chavez A., Citrin D., Janik J.E., Morris J.C. Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin Mol. Cancer 10 2011 35
    • (2011) Mol. Cancer , vol.10 , pp. 35
    • Kelly, R.J.1    Lopez-Chavez, A.2    Citrin, D.3    Janik, J.E.4    Morris, J.C.5
  • 16
    • 84878648322 scopus 로고    scopus 로고
    • Prognostic and clinicopathological significance of survivin in colorectal cancer: A meta-analysis
    • Krieg A., Werner T.A., Verde P.E., Stoecklein N.H., Knoefel W.T. Prognostic and clinicopathological significance of survivin in colorectal cancer: a meta-analysis PLoS One 8 2013 e65338
    • (2013) PLoS One , vol.8
    • Krieg, A.1    Werner, T.A.2    Verde, P.E.3    Stoecklein, N.H.4    Knoefel, W.T.5
  • 18
    • 77956495728 scopus 로고    scopus 로고
    • Ovarian cancer development and metastasis
    • Lengyel E. Ovarian cancer development and metastasis Am. J. Pathol. 177 2010 1053 1064
    • (2010) Am. J. Pathol. , vol.177 , pp. 1053-1064
    • Lengyel, E.1
  • 19
    • 84922496579 scopus 로고    scopus 로고
    • Tanshinone IIA inhibits HIF-1alpha and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway
    • Li G., Shan C., Liu L., Zhou T., Zhou J., Hu X., Chen Y., Cui H., Gao N. Tanshinone IIA inhibits HIF-1alpha and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway PLoS One 10 2015 e0117440
    • (2015) PLoS One , vol.10
    • Li, G.1    Shan, C.2    Liu, L.3    Zhou, T.4    Zhou, J.5    Hu, X.6    Chen, Y.7    Cui, H.8    Gao, N.9
  • 20
    • 78149464260 scopus 로고    scopus 로고
    • Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells
    • Liu H.F., Hu H.C., Chao J.I. Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells Chem. Biol. Interact. 188 2010 535 545
    • (2010) Chem. Biol. Interact. , vol.188 , pp. 535-545
    • Liu, H.F.1    Hu, H.C.2    Chao, J.I.3
  • 21
    • 84908032208 scopus 로고    scopus 로고
    • Aplysin sensitizes cancer cells to TRAIL by suppressing p38 MAPK/survivin pathway
    • Liu J., Ma L., Wu N., Liu G., Zheng L., Lin X. Aplysin sensitizes cancer cells to TRAIL by suppressing p38 MAPK/survivin pathway Mar. Drugs 12 2014 5072 5088
    • (2014) Mar. Drugs , vol.12 , pp. 5072-5088
    • Liu, J.1    Ma, L.2    Wu, N.3    Liu, G.4    Zheng, L.5    Lin, X.6
  • 22
    • 84898872892 scopus 로고    scopus 로고
    • Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: A meta-analysis
    • Lv S., Turlova E., Zhao S., Kang H., Han M., Sun H.S. Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis Tumour Biol. 35 2014 1565 1574
    • (2014) Tumour Biol. , vol.35 , pp. 1565-1574
    • Lv, S.1    Turlova, E.2    Zhao, S.3    Kang, H.4    Han, M.5    Sun, H.S.6
  • 23
    • 84919460678 scopus 로고    scopus 로고
    • Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer
    • Munagala R., Aqil F., Jeyabalan J., Gupta R.C. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer Cancer Lett. 356 2015 536 546
    • (2015) Cancer Lett. , vol.356 , pp. 536-546
    • Munagala, R.1    Aqil, F.2    Jeyabalan, J.3    Gupta, R.C.4
  • 24
    • 84861575622 scopus 로고    scopus 로고
    • Thiourea compound AW00178 sensitizes human H1299 lung carcinoma cells to TRAIL-mediated apoptosis
    • Ryu B.J., Hwang M.K., Park M., Lee K., Kim S.H. Thiourea compound AW00178 sensitizes human H1299 lung carcinoma cells to TRAIL-mediated apoptosis Bioorg. Med. Chem. Lett. 22 2012 3862 3865
    • (2012) Bioorg. Med. Chem. Lett. , vol.22 , pp. 3862-3865
    • Ryu, B.J.1    Hwang, M.K.2    Park, M.3    Lee, K.4    Kim, S.H.5
  • 25
    • 14844288360 scopus 로고    scopus 로고
    • Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: Paving the road to patient-tailored therapy
    • Van Geelen C.M., de Vries E.G., de Jong S. Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy Drug Resist. Update 7 2004 345 358
    • (2004) Drug Resist. Update , vol.7 , pp. 345-358
    • Van Geelen, C.M.1    De Vries, E.G.2    De Jong, S.3
  • 26
    • 8344271026 scopus 로고    scopus 로고
    • Production of recombinant protein therapeutics in cultivated mammalian cells
    • Wurm F.M. Production of recombinant protein therapeutics in cultivated mammalian cells Nat. Biotechnol. 22 2004 1393 1398
    • (2004) Nat. Biotechnol. , vol.22 , pp. 1393-1398
    • Wurm, F.M.1
  • 27
    • 0035464197 scopus 로고    scopus 로고
    • Survivin, bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas
    • Yoshida H., Ishiko O., Sumi T., Matsumoto Y., Ogita S. Survivin, bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas Int. J. Oncol. 19 2001 537 542
    • (2001) Int. J. Oncol. , vol.19 , pp. 537-542
    • Yoshida, H.1    Ishiko, O.2    Sumi, T.3    Matsumoto, Y.4    Ogita, S.5
  • 28
    • 0034532701 scopus 로고    scopus 로고
    • The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner
    • Zhao J., Tenev T., Martins L.M., Downward J., Lemoine N.R. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner J. Cell Sci. 113 2000 4363 4371
    • (2000) J. Cell Sci. , vol.113 , pp. 4363-4371
    • Zhao, J.1    Tenev, T.2    Martins, L.M.3    Downward, J.4    Lemoine, N.R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.